Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-08
2011-03-08
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07902180
ABSTRACT:
Association comprising agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in association with a thymoregulatory agent.Medicinal products containing the same which are useful in the treatment of mood disorders.
REFERENCES:
patent: 6395780 (2002-05-01), Arlt et al.
JD. Guelfi, et al., “Efficacy and safety of the new antidepressant agomelatine in combination with a mood stabilizer in bipolar I patients with a major depressive episode” Bipolar Disorders, vol. 7, No. Suppl. 2, p. 62, Jun. 2005.
Chilman-Blair, et al., “Agomelatine. Antidepressant treatment of bipolar disorder melatonin agonist/5-HT20 antagonist”, Drugs of the Future, vol. 28, No. 1, p. 7-13, Jan. 2003.
French Preliminary Search Report for 05.09208 of Apr. 27, 2006.
Hueschen and Sage
Hughes Alicia R
Les Laboratoires Servier
Marschel Ardin
LandOfFree
Association between agomelatine and a thymoregulatory agent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Association between agomelatine and a thymoregulatory agent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Association between agomelatine and a thymoregulatory agent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719768